FdaApplication
ANDA 204785
Identifiers
- fda_app_no: ANDA204785
Properties
| Property | Value |
|---|---|
| applicant_name | KEY THERAPEUTICS LLC |
| application_type | ANDA |
| approval_date | 2014-11-26 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TREZIX | ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE | 320.5MG;30MG;16MG | CAPSULE;ORAL |
1 product